Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Cash from Investing Activities (2019 - 2023)

Historic Cash from Investing Activities for ADC Therapeutics (ADCT) over the last 5 years, with Q4 2023 value amounting to -$327000.0.

  • ADC Therapeutics' Cash from Investing Activities rose 5223.55% to -$327000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was -$3.2 million, marking a year-over-year decrease of 36812.23%. This contributed to the annual value of -$867000.0 for FY2024, which is 7304.1% up from last year.
  • As of Q4 2023, ADC Therapeutics' Cash from Investing Activities stood at -$327000.0, which was up 5223.55% from -$661000.0 recorded in Q3 2023.
  • Over the past 5 years, ADC Therapeutics' Cash from Investing Activities peaked at -$47.0 during Q3 2019, and registered a low of -$1.2 million during Q2 2023.
  • Over the past 5 years, ADC Therapeutics' median Cash from Investing Activities value was -$2338.0 (recorded in 2021), while the average stood at -$293734.3.
  • As far as peak fluctuations go, ADC Therapeutics' Cash from Investing Activities surged by 9986.75% in 2021, and later plummeted by 26013622.05% in 2023.
  • Over the past 5 years, ADC Therapeutics' Cash from Investing Activities (Quarter) stood at -$294.0 in 2019, then plummeted by 168607.48% to -$496000.0 in 2020, then skyrocketed by 99.83% to -$830.0 in 2021, then plummeted by 82383.01% to -$684609.0 in 2022, then surged by 52.24% to -$327000.0 in 2023.
  • Its Cash from Investing Activities was -$327000.0 in Q4 2023, compared to -$661000.0 in Q3 2023 and -$1.2 million in Q2 2023.